Higher antibody level correlates with greater vaccine protection against COVID-19 - News-Medical.net
By measuring antibodies against the SARS-CoV-2 spike protein in participants in a phase 3 trial of the Moderna COVID-19 vaccine, researchers found that the higher the antibody level, the greater the vaccine protection against COVID-19.
By measuring antibodies against the SARS-CoV-2 spike protein in participants in a phase 3 trial of the Moderna COVID-19 vaccine, researchers found that the higher the antibody level, the greater the … [+2151 chars]
Read More
Other Stories in Health
- Nailfold Capillaroscopy May Aid Retinopathy Management in T2D
- Ultraprocessed Food Tied to Respiratory Function in Asthma
- Wally Lewis announces $12.5 million federal government program for CTE awareness
- Peristaltic pumping motion found to trigger amyloid formation
- NIDUS-Family care package reduces dementia support costs
- SGEM Memes AI for Clinical Research
- UVA receives $9.3 million NIH grant for ketamine seizure treatment trial
- Childhood cancer: A growing concern
- 8 daily exercises to reduce cholesterol levels naturally and detox our body
.png)
